Identification of and Structural Insights into Hit Compounds

Structure-based molecular modeling in SAR analysis and lead optimization - ScienceDirect

High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need - ScienceDirect

Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery - Computational and Structural Biotechnology Journal

Adopting AI in Drug Discovery

Drug Discovery Services

Solutions for challenging targets with difficulty in hit identification - Axcelead Drug Discovery Partners, Inc.

Computational approaches streamlining drug discovery

Accelerating drug target inhibitor discovery with a deep generative foundation model

Advances in covalent drug discovery

What are the differences between a hit and a lead in drug discovery? - Quora

Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds: Trends in Pharmacological Sciences

Kinases and Phosphatases, Free Full-Text

Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors

Hit Identification (Hit ID)

Cryo-EM structures of human GPR34 enable the identification of selective antagonists